Triazole beta carboline derivatives as antidiabetic compounds

Details for Australian Patent Application No. 2009309008 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Guo, Liangqin; Liu, Jian; Nargund, Ravi P.; Pasternak, Alexander; Yang, Lihu; Ye, Zhixiong

Agent Spruson & Ferguson

Pub. Number AU-A-2009309008

PCT Pub. Number WO2010/051177

Priority 61/197,597 29.10.08 US

Filing date 19 October 2009

Wipo publication date 6 May 2010

International Classifications

A01N 43/42 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/051177 Priority application(s): WO2010/051177

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009309019-P2X3, receptor antagonists for treatment of pain

2009309007-Novel cyclic benzimidazole derivatives useful anti-diabetic agents